A study investigating the treatment of equine squamous gastric disease with long‐acting injectable or oral omeprazole
Abstract Background Equine squamous gastric disease (ESGD) is a highly prevalent disease in horses, particularly in elite athletes. Some horses respond slowly, or fail to respond, to the licensed treatment, oral omeprazole (ORLO). Objectives To compare rates of ESGD healing and improvement between O...
Main Authors: | Sarah Gough, Gayle Hallowell, David Rendle |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-05-01
|
Series: | Veterinary Medicine and Science |
Subjects: | |
Online Access: | https://doi.org/10.1002/vms3.220 |
Similar Items
-
EARLY PARENTERAL USE OF PROTON PUMP INHIBITORS IN THE COMPLEx TREATMENT OF ACUTE POISONING WITH CAUTERANT AGENTS
by: K. K. Ilyashenko, et al.
Published: (2016-03-01) -
Electrolyte disturbances in children receiving omeprazole for gastroesophageal reflux disease
by: Fatemeh Famouri, et al.
Published: (2020-01-01) -
A Common Worm in a Rare Place.
by: Mohammed Reza Sheikhian
Published: (2013-11-01) -
Efficacy of the four weeks treatment of omeprazole plus mosapride combination therapy compared with that of omeprazole monotherapy in patients with proton pump inhibitor-refractory gastroesophageal reflux disease: a randomized controlled trial
by: Sirinawasatien A, et al.
Published: (2019-07-01) -
Ticagrelor and omeprazole: A desirable combination in post MI patients?
by: Dimitrios Alexopoulos
Published: (2020-09-01)